Showing results (911-920 of 986) with videos related to

Sort By:
Pageof 99
Cancer|December 2, 2022
A retrospective study of cladribine and low-dose cytarabine-based regimens for the treatment of chronic myelomonocytic leukemia and secondary acute myeloid leukemiaAlexandre Bazinet, Faezeh Darbaniyan, Tapan M Kadia, et al.
Leukemia Research|August 23, 2024
Characteristics and outcomes of children, adolescent, and young adult patients with myelodysplastic neoplasms: A single-center retrospective analysisDavid McCall, Tareq Abuasab, Juan Jose Rodriguez-Sevilla, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 21, 2014
Panel-based genetic diagnostic testing for inherited eye diseases is highly accurate and reproducible, and more sensitive for variant detection, than exome sequencingMark B Consugar, Daniel Navarro-Gomez, Emily M Place, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2019
The Changing Epidemiology of Candidemia in the United States: Injection Drug Use as an Increasingly Common Risk Factor-Active Surveillance in Selected Sites, United States, 2014-2017Alexia Y Zhang, Sarah Shrum, Sabrina Williams, et al.
Drug and Alcohol Dependence Reports|January 23, 2024
Pilot study of a community pharmacist led program to treat hepatitis C virus among people who inject drugsJ I Tsui, A J Gojic, K A Pierce, et al.
Cancer|June 1, 2016
Malignancy-associated hemophagocytic lymphohistiocytosis in adults: Relation to hemophagocytosis, characteristics, and outcomesGevorg N Tamamyan, Hagop M Kantarjian, Jing Ning, et al.
Plos Genetics|September 29, 2025
Identifying genetic determinants of outer retinal function in mice using a large-scale gene-targeted screenJanine M Wotton, Mark P Krebs, Riccardo Sangermano, et al.
Science Translational Medicine|February 11, 2012
AAV2 gene therapy readministration in three adults with congenital blindnessJean Bennett, Manzar Ashtari, Jennifer Wellman, et al.
Human Mutation|March 17, 2010
Prognosis for splicing factor PRPF8 retinitis pigmentosa, novel mutations and correlation between human and yeast phenotypesKatherine V Towns, Athina Kipioti, Vernon Long, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 30, 2025
Outcomes of Patients With IDH1-Mutated Myeloid Neoplasms Treated With OlutasidenibKelly S Chien, Sanam Loghavi, Koji Sasaki, et al.
Pageof 99